LDL Receptor Appearance as a Diagnostic Early Detector
Detecting widespread Low Density Lipoprotein Receptor (LDLR) expression in microscopic slides of brain tumor samples.
DNKO
Focus Areas
GlioDAO is dedicated to funding the development of transformative and translational treatments for brain cancer. We prioritze funding specifically for Glioblastoma Multiforme (GBM), Anaplastic Astrocytoma (Grade III & IV), and Diffuse Midline Gliomas (DMG), but may expand to other rare forms of brain cancer.
Our goal is to fund high-risk, early-stage research to move promising studies past the Valley of Death. As a cure-motivated community, we are not constrained by shareholders or investors and are willing to invest in moonshots, translating projects to a point where private funding is more likely to be successful.
We prioritize funding research across four key categories, however, we remain open to other exceptional projects if they strongly align with our mission and potential for impact.
Novel Therapeutics
- • Medical Devices
- • Immunotherapies & Vaccines
- • Innovative Drugs
Biopsy & Early Detection
- • Liquid Biopsy
- • Advanced Imaging
- • AI/ ML Applications
Drug Delivery
- • Viral-vector Delivery
- • Blood Brain Barrier Opening
- • Tumor Site Delivery
Patient Products
- • Patient Support
- • Recurrence Detection
- • QoL Tracking Apps
Funding Process
Once you submit a preliminary application, our Neuro-Oncology Working Group will offer feedback and help refine your proposal to meet high-impact research and industry standards. After revisions, your final application goes to a community vote, with funding decisions made in under a month. If not approved, you're encouraged to revise based on feedback and reapply.
Turning Research into Digital Assets
What is an IP-NFT?
An IP-NFT (Intellectual Property Non-Fungible Token) represents the rights to a research project, including agreements, licenses, and data, stored securely on the blockchain.
How it works
Mint
Legal agreements and IP are bundled into a digital contract and minted as an IP-NFT.
Tokenize
The IP-NFT can then be broken into smaller pieces called IP Tokens.
Own & Support
$GLIO holders can purchase these IP Tokens to help directly fund research and manage IP outcomes.
This system makes it easier to fund, track, and support breakthrough brain cancer research, while giving the community a say in the innovation it helps unlock.
Our Projects
Machine Learning-Assisted Early Detection
An AI-driven study to enhance GBM diagnosis by refining texture-based histopathological analysis across diverse datasets
To Be Determined
Assessing GBM Isolation Through Digital Phenotyping
A digital phenotyping study using passive data to assess social isolation in GBM patients and caregivers
OurBrainBank